| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |